112 related articles for article (PubMed ID: 7540234)
1. Natural state of mutant p53 protein and heat shock protein 70 in breast cancer tissues.
Iwaya K; Tsuda H; Fujita S; Suzuki M; Hirohashi S
Lab Invest; 1995 Jun; 72(6):707-14. PubMed ID: 7540234
[TBL] [Abstract][Full Text] [Related]
2. p53 protein accumulation detected by five different antibodies: relationship to prognosis and heat shock protein 70 in breast cancer.
Elledge RM; Clark GM; Fuqua SA; Yu YY; Allred DC
Cancer Res; 1994 Jul; 54(14):3752-7. PubMed ID: 8033095
[TBL] [Abstract][Full Text] [Related]
3. [Comparison of nuclear accumulation of p53 protein with mutations in the p53 gene on the tissues of human breast cancer].
Fan P; Wu Z; Cha X; Wang X; Wang S
Zhonghua Wai Ke Za Zhi; 1998 Nov; 36(11):655-7. PubMed ID: 11825490
[TBL] [Abstract][Full Text] [Related]
4. Multiple p53 protein isoforms and formation of oligomeric complexes with heat shock proteins Hsp70 and Hsp90 in the human mammary tumor, T47D, cell line.
Selkirk JK; Merrick BA; Stackhouse BL; He C
Appl Theor Electrophor; 1994; 4(1):11-8. PubMed ID: 7811761
[TBL] [Abstract][Full Text] [Related]
5. p53 gene mutation in relation to p53 protein accumulation in male and female breast cancer.
Nayak BK; Baral RN; Das BR
Neoplasma; 1996; 43(5):305-10. PubMed ID: 8996549
[TBL] [Abstract][Full Text] [Related]
6. Inhibition mechanism of a newly cloned candidate tumor suppressor gene JST during hepatocarcinogenesis and its abnormal expression in human hepatocellular carcinoma from Qidong liver cancer risk area, China.
Dong-Dong L; Xi-Ran Z
Hepatogastroenterology; 2004; 51(56):515-25. PubMed ID: 15086194
[TBL] [Abstract][Full Text] [Related]
7. A comparison between p53 accumulation determined by immunohistochemistry and TP53 mutations as prognostic variables in tumours from breast cancer patients.
Alsner J; Jensen V; Kyndi M; Offersen BV; Vu P; Børresen-Dale AL; Overgaard J
Acta Oncol; 2008; 47(4):600-7. PubMed ID: 18465328
[TBL] [Abstract][Full Text] [Related]
8. p53 gene mutation and protein accumulation during neoplastic progression in Barrett's esophagus.
Bian YS; Osterheld MC; Bosman FT; Benhattar J; Fontolliet C
Mod Pathol; 2001 May; 14(5):397-403. PubMed ID: 11353048
[TBL] [Abstract][Full Text] [Related]
9. Mouse mammary tumor-like virus is associated with p53 nuclear accumulation and progesterone receptor positivity but not estrogen positivity in human female breast cancer.
Faedo M; Ford CE; Mehta R; Blazek K; Rawlinson WD
Clin Cancer Res; 2004 Jul; 10(13):4417-9. PubMed ID: 15240531
[TBL] [Abstract][Full Text] [Related]
10. [The colocalized relationship between p53 mutants 249M, 273H and hsp70 in HepG2 cells].
Liu ZF; Wang Q; Yang SJ
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Apr; 25(4):296-8. PubMed ID: 19351493
[TBL] [Abstract][Full Text] [Related]
11. Structural alteration of p53 protein in patients with muscle invasive bladder transitional cell carcinoma.
Tiguert R; Bianco FJ; Oskanian P; Li Y; Grignon DJ; Wood DP; Pontes JE; Sarkar FH
J Urol; 2001 Dec; 166(6):2155-60. PubMed ID: 11696726
[TBL] [Abstract][Full Text] [Related]
12. p53 Alterations and protein accumulation in benign breast tissue and breast cancer risk: a cohort study.
Rohan TE; Li SQ; Hartwick R; Kandel RA
Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1316-23. PubMed ID: 16835330
[TBL] [Abstract][Full Text] [Related]
13. An immunohistochemical analysis of heat shock protein 70, p53, and estrogen receptor status in carcinoma of the uterine cervix.
Park CS; Joo IS; Song SY; Kim DS; Bae DS; Lee JH
Gynecol Oncol; 1999 Jul; 74(1):53-60. PubMed ID: 10385551
[TBL] [Abstract][Full Text] [Related]
14. Mutations in p53 are frequent in the preneoplastic stage of mouse mammary tumor development.
Jerry DJ; Ozbun MA; Kittrell FS; Lane DP; Medina D; Butel JS
Cancer Res; 1993 Jul; 53(14):3374-81. PubMed ID: 8324748
[TBL] [Abstract][Full Text] [Related]
15. p53 mutations are confined to the comedo type ductal carcinoma in situ of the breast. Immunohistochemical and sequencing data.
O'Malley FP; Vnencak-Jones CL; Dupont WD; Parl F; Manning S; Page DL
Lab Invest; 1994 Jul; 71(1):67-72. PubMed ID: 8041120
[TBL] [Abstract][Full Text] [Related]
16. p53 immunoreactivity and single-strand conformational polymorphism analysis often fail to predict p53 mutational status.
Tolbert DM; Noffsinger AE; Miller MA; DeVoe GW; Stemmermann GN; Macdonald JS; Fenoglio-Preiser CM
Mod Pathol; 1999 Jan; 12(1):54-60. PubMed ID: 9950163
[TBL] [Abstract][Full Text] [Related]
17. Heat shock proteins and cell proliferation in human breast cancer biopsy samples.
Vargas-Roig LM; Fanelli MA; López LA; Gago FE; Tello O; Aznar JC; Ciocca DR
Cancer Detect Prev; 1997; 21(5):441-51. PubMed ID: 9307847
[TBL] [Abstract][Full Text] [Related]
18. Accumulation of p53 protein as an indicator for p53 gene mutation in breast cancer. Occurrence of false-positives and false-negatives.
Lohmann D; Ruhri C; Schmitt M; Graeff H; Höfler H
Diagn Mol Pathol; 1993 Mar; 2(1):36-41. PubMed ID: 8287224
[TBL] [Abstract][Full Text] [Related]
19. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan.
Wang YC; Chen CY; Chen SK; Cherng SH; Ho WL; Lee H
Cancer Res; 1998 Jan; 58(2):328-33. PubMed ID: 9443413
[TBL] [Abstract][Full Text] [Related]
20. Mutant p53 protein overexpression in women with ipsilateral breast tumor recurrence following lumpectomy and radiation therapy.
Turner BC; Gumbs AA; Carbone CJ; Carter D; Glazer PM; Haffty BG
Cancer; 2000 Mar; 88(5):1091-8. PubMed ID: 10699900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]